<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2025-4-104-110</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-6268</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Расширенная диагностика патологий шейки матки</article-title><trans-title-group xml:lang="en"><trans-title>Extended diagnosis of cervical lesions</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1521-9668</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернов</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernov</surname><given-names>D. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чернов Денис Юрьевич – аспирант, кафедра акушерства и гинекологии</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2 Moscovsky trakt, 634050 Tomsk</p></bio><email xlink:type="simple">denis.chrnv1@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4309-5831</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тихоновская</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tikhonovskaya</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тихоновская Ольга Анатольевна – д-р мед. наук, профессор кафедры акушерства и гинекологии</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2 Moscovsky trakt, 634050 Tomsk</p></bio><email xlink:type="simple">tikhonovskaya2012@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9876-6957</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логвинов</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Logvinov</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Логвинов Сергей Валентинович – д-р мед. наук, профессор, зав. кафедрой гистологии, эмбриологии и цитологии</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2 Moscovsky trakt, 634050 Tomsk</p></bio><email xlink:type="simple">sLogvinov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0468-3959</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Потапов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Potapov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Потапов Алексей Валерьевич – д-р мед. наук, профессор кафедры гистологии, эмбриологии и цитологии</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2 Moscovsky trakt, 634050 Tomsk</p></bio><email xlink:type="simple">potalex@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8526-6187</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Герасимов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gerasimov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Герасимов Александр Владимирович – д-р мед. наук, доцент, профессор кафедры гистологии, эмбриологии и цитологии</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2 Moscovsky trakt, 634050 Tomsk</p></bio><email xlink:type="simple">av-gerasimov62@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7226-0328</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Геренг</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gereng</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Геренг Елена Андреевна – д-р мед. наук, доцент, профессор кафедры морфологии и общей патологии</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2 Moscovsky trakt, 634050 Tomsk</p></bio><email xlink:type="simple">e-gereng@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0680-8249</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акбашева</surname><given-names>О. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Akbasheva</surname><given-names>D. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Акбашева Ольга Евгеньевна – д-р мед. наук, профессор кафедры биохимии и молекулярной биологии с курсом клинической лабораторной диагностики</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2 Moscovsky trakt, 634050 Tomsk</p></bio><email xlink:type="simple">Akbashoe@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3274-6010</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ласукова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lasukova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ласукова Татьяна Викторовна – д-р биол. наук, профессор кафедры нормальной физиологии</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2 Moscovsky trakt, 634050 Tomsk</p></bio><email xlink:type="simple">tlasukova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет (СибГМУ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>12</day><month>01</month><year>2026</year></pub-date><volume>24</volume><issue>4</issue><fpage>104</fpage><lpage>110</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чернов Д.Ю., Тихоновская О.А., Логвинов С.В., Потапов А.В., Герасимов А.В., Геренг Е.А., Акбашева О.Е., Ласукова Т.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Чернов Д.Ю., Тихоновская О.А., Логвинов С.В., Потапов А.В., Герасимов А.В., Геренг Е.А., Акбашева О.Е., Ласукова Т.В.</copyright-holder><copyright-holder xml:lang="en">Chernov D.Y., Tikhonovskaya O.A., Logvinov S.V., Potapov A.V., Gerasimov A.V., Gereng E.A., Akbasheva D.E., Lasukova T.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/6268">https://bulletin.ssmu.ru/jour/article/view/6268</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: повышение эффективности диагностики патологий шейки матки с использованием цитологической диагностики и полимеразной цепной реакции (ПЦР) на вирус папилломы человека (ВПЧ), с учетом выявления персистенции ВПЧ в верхних отделах цервикального канала.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В группу исследования включены пациентки (n = 60) с патологией шейки матки. Выполнены цитологические исследования с верификацией диагноза по классификации The Bethesda system и распределены пациентки на группы в соответствии с результатами: I (n = 22) – negative for intraepithelial lesion or malignancy (NILM), II (n = 18) – low-grade squamous intraepithelial lesion (L-SIL), III (n = 12) highgrade squamous intraepithelial lesion (H-SIL), IV (n = 8) atypical squamous cells of undetermined significance (Asc-Us). Проведены стандартная ПЦР-диагностика ВПЧ и ПЦР гомогената эндоцервикального компонента методами Hybrid Capture Digene test (панель 14 онкосеротипов) для выявления ВПЧ в верхних отделах цервикального канала (патент № 2833119 от 14.12.2023).</p></sec><sec><title>Результаты</title><p>Результаты. Персистенция ВПЧ в верхних отделах цервикального канала выявлена у 45 (75%) из 60 пациенток. ВПЧ диагностирован достоверно (p = 0,0157) чаще у пациенток с результатами онкоцитологии L-SIL и H-SIL – в 89% (16/18) и 100% (12/12) случаях соответственно. ВПЧ в верхних отделах цервикального канала обнаружен у 59% (13/22) пациенток группы NILM и 50% (4/8) пациенток группы Asc-US. Высока частота расхождений в структуре выявленных штаммов ВПЧ при проведении стандартного ПЦР и ПЦР гомогената, сопоставима для всех групп: NILM 64% (14/22); L-SIL 61% (11/18); H-SIL 58% (7/12); Asc-Us 75% (6/8), p &gt; 0,05. Персистенция ВПЧ в верхних отделах цервикального канала при негативных результатах стандартной ПЦР выявлена у 41% (9/22) пациенток с NILM. Высокая вирусная нагрузка в гомогенате определялась чаще у пациенток группы H-SIL (p = 0,0374).</p></sec><sec><title>Заключение</title><p>Заключение. Расширение диагностики позволяет в полной мере оценить степень вовлечения шейки матки в патологический процесс и определить оптимальную тактику ведения у женщин с высокой степенью риска (H-SIL, рецидивы L-SIL, высокая вирусная нагрузка ВПЧ).</p></sec><sec><title> </title><p> </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To improve the efficiency of diagnosing cervical pathologies using cytology and polymerase chain reaction (PCR) for human papillomavirus (HPV), taking into account the detection of HPV in upper parts of the endocervix.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study involved 60 patients with cervical pathology. The results of the cytological studies were verified according to The Bethesda system; the patients were divided into groups based on the results: Group I (n = 22) – negative for intraepithelial lesion or malignancy (NILM), Group II (n = 18) – low-grade squamous intraepithelial lesion (L-SIL), Group III (n = 12) – high-grade squamous intraepithelial lesion (H-SIL), Group IV (n = 8) – atypical squamous cells of undetermined significance (ASC-US). Standard PCR testing for HPV and PCR of the endocervical homogenate were conducted using the Hybrid Capture Digene test (RF Patent No. 2833119 dated December 14, 2023).</p></sec><sec><title>Results</title><p>Results. Persistence of HPV in the upper endocervix was detected in 45 (75%) of patients. HPV was diagnosed significantly more often (p = 0.0157) in patients with L-SIL and H-SIL cytology – in 89% (16/18) и 100% (12/12) cases, respectively. Oncogenic HPV serotypes were found in 59% (13/22) of patients with NILM and in 50% (4/8) of patients with ASC-US. High frequency of discrepancies in the profile of the detected HPV strains between standard PCR and homogenate PCR testing was observed and was comparable across all groups: NILM 64% (14/22); L-SIL 61% (11/18); H-SIL 58% (7/12); ASC-US 75% (6/8), p &gt; 0,05. Persistence of HPV in the upper parts of the cervix with negative standard PCR results was detected in 41% (9/22) of patients with NILM. A high viral load in the homogenate was detected more frequently in patients of the H-SIL group (p = 0.0374).</p></sec><sec><title>Conclusion</title><p>Conclusion. Extended diagnosis allows for a comprehensive assessment of the degree of cervical involvement in the pathology and helps determine the optimal management strategy for women at high risk (H-SIL, recurrent L-SIL, HPV persistence with high viral load).</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>патология шейки матки</kwd><kwd>вирус папилломы человека</kwd><kwd>персистенция</kwd><kwd>диагностика</kwd><kwd>ПЦР</kwd><kwd>цитология</kwd><kwd>гомогенат</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cervical pathology</kwd><kwd>human papillomavirus</kwd><kwd>persistence</kwd><kwd>diagnosis</kwd><kwd>PCR</kwd><kwd>cytology</kwd><kwd>homogenate</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y., Qiu K., Ren J., Zhao Y., Cheng P. Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use. Signal Transduct. Target. Ther. 2025;10(1):44. DOI: 10.1038/s41392-024-02083-w.</mixed-citation><mixed-citation xml:lang="en">Zhang Y., Qiu K., Ren J., Zhao Y., Cheng P. Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use. Signal Transduct. Target. Ther. 2025;10(1):44. DOI: 10.1038/s41392-024-02083-w.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.</mixed-citation><mixed-citation xml:lang="en">Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кондриков Н.И., Баринова И.В. Патология матки. Руководство для врачей; 2-е изд. М.: Практическая медицина, 2019:352.</mixed-citation><mixed-citation xml:lang="en">Кондриков Н.И., Баринова И.В. Патология матки. Руководство для врачей; 2-е изд. М.: Практическая медицина, 2019:352.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J.Y., Wang Z.L., Wang Z.Y., Yang X.S. The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization. Medicine (Baltimore). 2018;97(41):12792. DOI: 10.1097/MD.0000000000012792.</mixed-citation><mixed-citation xml:lang="en">Chen J.Y., Wang Z.L., Wang Z.Y., Yang X.S. The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization. Medicine (Baltimore). 2018;97(41):12792. DOI: 10.1097/MD.0000000000012792.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rayner M., Welp A., Stoler M.H., Cantrell L.A. Cervical cancer screening recommendations: Now and for the Future. Healthcare (Basel). 2023;11(16):2273. DOI: 10.3390/healthcare11162273.</mixed-citation><mixed-citation xml:lang="en">Rayner M., Welp A., Stoler M.H., Cantrell L.A. Cervical cancer screening recommendations: Now and for the Future. Healthcare (Basel). 2023;11(16):2273. DOI: 10.3390/healthcare11162273.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Feng T., Cheng B., Sun W., Yang Y. Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions. BMC Womens Health. 2023;23(1):599. DOI: 10.1186/s12905-023-02764-8.</mixed-citation><mixed-citation xml:lang="en">Feng T., Cheng B., Sun W., Yang Y. Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions. BMC Womens Health. 2023;23(1):599. DOI: 10.1186/s12905-023-02764-8.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Adebamowo S.N., Befano B., Cheung L.C., Rodriguez A.C., Demarco M., Rydzak G. et al. Different human papillomavirus types share early natural history transitions in immunocompetent women. Int. J. Cancer. 2022;151(6):920–929. DOI: 10.1002/ijc.34128.</mixed-citation><mixed-citation xml:lang="en">Adebamowo S.N., Befano B., Cheung L.C., Rodriguez A.C., Demarco M., Rydzak G. et al. Different human papillomavirus types share early natural history transitions in immunocompetent women. Int. J. Cancer. 2022;151(6):920–929. DOI: 10.1002/ijc.34128.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Louvanto K., Syrjänen K.J., Rintala M.A., Grénman S.E., Syrjänen S.M. Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study. J. Clin. Microbiol. 2010;48(8):2665–2671. DOI: 10.1128/JCM.00783-10.</mixed-citation><mixed-citation xml:lang="en">Louvanto K., Syrjänen K.J., Rintala M.A., Grénman S.E., Syrjänen S.M. Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study. J. Clin. Microbiol. 2010;48(8):2665–2671. DOI: 10.1128/JCM.00783-10.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Curry S.J., Krist A.H., Owens D.K., Barry M.J., Caughey A.B. et al. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674–686. DOI: 10.1001/jama.2018.10897.</mixed-citation><mixed-citation xml:lang="en">Curry S.J., Krist A.H., Owens D.K., Barry M.J., Caughey A.B. et al. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674–686. DOI: 10.1001/jama.2018.10897.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Feldstein O., Gali-Zamir H., Schejter E., Feinberg T., Yehuda-Shnaidman E., Bornstein J. et al. High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study. Acta. Obstet. Gynecol. Scand. 2023;102(2):226–233. DOI: 10.1111/aogs.14482. Epub 2022 Dec 7.</mixed-citation><mixed-citation xml:lang="en">Feldstein O., Gali-Zamir H., Schejter E., Feinberg T., Yehuda-Shnaidman E., Bornstein J. et al. High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study. Acta. Obstet. Gynecol. Scand. 2023;102(2):226–233. DOI: 10.1111/aogs.14482. Epub 2022 Dec 7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.</mixed-citation><mixed-citation xml:lang="en">WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tai Y.J., Chen Y.Y., Hsu H.C., Chiang C.J., You S.L., Chen H.C. et al. Taiwan Cervical Cancer Control Task Force. Clinical management and risk reduction in women with lowgrade squamous intraepithelial lesion cytology: A population-based cohort study. PLoS One. 2017;12(12):e0188203. DOI: 10.1371/journal.pone.0188203.</mixed-citation><mixed-citation xml:lang="en">Tai Y.J., Chen Y.Y., Hsu H.C., Chiang C.J., You S.L., Chen H.C. et al. Taiwan Cervical Cancer Control Task Force. Clinical management and risk reduction in women with lowgrade squamous intraepithelial lesion cytology: A population-based cohort study. PLoS One. 2017;12(12):e0188203. DOI: 10.1371/journal.pone.0188203.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Buick C., Jembere N., Wang L., Kupets R. Cervical screening and colposcopy management of women age 24 and under. J. Obstet. Gynaecol. Can. 2020;42(12):1518–1524. DOI: 10.1016/j.jogc.2020.06.013.</mixed-citation><mixed-citation xml:lang="en">Buick C., Jembere N., Wang L., Kupets R. Cervical screening and colposcopy management of women age 24 and under. J. Obstet. Gynaecol. Can. 2020;42(12):1518–1524. DOI: 10.1016/j.jogc.2020.06.013.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Min C.J., Massad L.S., Dick R., Powell M.A., Kuroki L.M. Assessing physician adherence to guidelines for cervical cancer screening and management of abnormal screening results. J. Low. Genit. Tract. Dis. 2020;24(4):337–342. DOI: 10.1097/LGT.0000000000000558.</mixed-citation><mixed-citation xml:lang="en">Min C.J., Massad L.S., Dick R., Powell M.A., Kuroki L.M. Assessing physician adherence to guidelines for cervical cancer screening and management of abnormal screening results. J. Low. Genit. Tract. Dis. 2020;24(4):337–342. DOI: 10.1097/LGT.0000000000000558.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Malagón T., Volesky K.D., Bouten S., Laprise C., El-Zein M., Franco E.L. Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis. Int. J. Cancer. 2020;147(10):2695–2707. DOI: 10.1002/ijc.33035.</mixed-citation><mixed-citation xml:lang="en">Malagón T., Volesky K.D., Bouten S., Laprise C., El-Zein M., Franco E.L. Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis. Int. J. Cancer. 2020;147(10):2695–2707. DOI: 10.1002/ijc.33035.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kang W.D., Ju U.C., Kim S.M. Human papillomavirus genotyping for predicting disease progression in women with biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade intraepithelial lesion cytology. Int. J. Gynecol. Cancer. 2024;34(1):12–18. DOI: 10.1136/ijgc2023-004902.</mixed-citation><mixed-citation xml:lang="en">Kang W.D., Ju U.C., Kim S.M. Human papillomavirus genotyping for predicting disease progression in women with biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade intraepithelial lesion cytology. Int. J. Gynecol. Cancer. 2024;34(1):12–18. DOI: 10.1136/ijgc2023-004902.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Firnhaber C., Swarts A., Goeieman B., Rakhombe N., Mulongo M., Williamson A.L. et al. Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial. J. Acquir. Immune. Defic. Syndr. 2017;76(5):532–538. DOI: 10.1097/QAI.0000000000001539.</mixed-citation><mixed-citation xml:lang="en">Firnhaber C., Swarts A., Goeieman B., Rakhombe N., Mulongo M., Williamson A.L. et al. Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial. J. Acquir. Immune. Defic. Syndr. 2017;76(5):532–538. DOI: 10.1097/QAI.0000000000001539.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou D., Xue J., Sun Y., Zhu L., Zhao M., Cui M. et al. Patterns of single and multiple HPV infections in female: A systematic review and meta-analysis. Heliyon. 2024;10(17):e35736. DOI: 10.1016/j.heliyon.2024.e35736.</mixed-citation><mixed-citation xml:lang="en">Zhou D., Xue J., Sun Y., Zhu L., Zhao M., Cui M. et al. Patterns of single and multiple HPV infections in female: A systematic review and meta-analysis. Heliyon. 2024;10(17):e35736. DOI: 10.1016/j.heliyon.2024.e35736.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tao X., Zhang H., Zhang H., Xiao Y., Zhong F., Zhou X. et al. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases. Cancer Cytopathol. 2022;130(7):542– 550. DOI: 10.1002/cncy.22573.</mixed-citation><mixed-citation xml:lang="en">Tao X., Zhang H., Zhang H., Xiao Y., Zhong F., Zhou X. et al. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases. Cancer Cytopathol. 2022;130(7):542– 550. DOI: 10.1002/cncy.22573.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ni X., Hu J., Huang Y., Tao J., Zhu H. Higher clearance rates of multiple HPV infections may explain their lower risk of HSIL: A retrospective study in Wenzhou, China. J. Med. Virol. 2023;95(2):e28526. DOI: 10.1002/jmv.28526. PMID: 36698241.</mixed-citation><mixed-citation xml:lang="en">Ni X., Hu J., Huang Y., Tao J., Zhu H. Higher clearance rates of multiple HPV infections may explain their lower risk of HSIL: A retrospective study in Wenzhou, China. J. Med. Virol. 2023;95(2):e28526. DOI: 10.1002/jmv.28526. PMID: 36698241.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y., Ni Z., Wei T., Liu Q. Persistent HPV infection after conization of cervical intraepithelial neoplasia - a systematic review and meta-analysis. BMC Womens Health. 2023;23(1):216. DOI: 10.1186/s12905-023-02360-w.</mixed-citation><mixed-citation xml:lang="en">Zhang Y., Ni Z., Wei T., Liu Q. Persistent HPV infection after conization of cervical intraepithelial neoplasia - a systematic review and meta-analysis. BMC Womens Health. 2023;23(1):216. DOI: 10.1186/s12905-023-02360-w.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
